中华医院管理杂志
中華醫院管理雜誌
중화의원관리잡지
CHINESE JOURNAL OF HOSPITAL ADMINISTRATION
2010年
2期
126-130
,共5页
龚时薇%张亮%金肆%李琳琳
龔時薇%張亮%金肆%李琳琳
공시미%장량%금사%리림림
罕见病%罕用药%药品可及性%药事管理
罕見病%罕用藥%藥品可及性%藥事管理
한견병%한용약%약품가급성%약사관리
Rare diseases%Orphan drug%Drug accessibility%Drug management
目的 探索提高我国罕见病患者用药可及性的管理策略.方法 通过对我国近年典型罕见病用药事件进行分析研究、对医院管理和临床医疗专家进行访谈式问卷调查,以及对我国目前罕用药医疗保险政策进行分析研究,确定药品可及性的含义,明确影响罕见病患者用药可及性的障碍因素.结果 我国医药卫生系统目前主要在科技、供应、信息传递和医疗保障能力四个方面存在主、客观障碍因素,影响罕见病患者用药的可及性,患者呈现出用不到药、用药不及时和用不起药的特点.结论 提高我国罕见病患者用药的可及性,应明确罕见病与罕用药的基本概念和激励机制,设计提高医药卫生系统罕用药供应的反应性机制,构建政府、企业、患者三维主体协作模式,降低患者的经济负担.
目的 探索提高我國罕見病患者用藥可及性的管理策略.方法 通過對我國近年典型罕見病用藥事件進行分析研究、對醫院管理和臨床醫療專傢進行訪談式問捲調查,以及對我國目前罕用藥醫療保險政策進行分析研究,確定藥品可及性的含義,明確影響罕見病患者用藥可及性的障礙因素.結果 我國醫藥衛生繫統目前主要在科技、供應、信息傳遞和醫療保障能力四箇方麵存在主、客觀障礙因素,影響罕見病患者用藥的可及性,患者呈現齣用不到藥、用藥不及時和用不起藥的特點.結論 提高我國罕見病患者用藥的可及性,應明確罕見病與罕用藥的基本概唸和激勵機製,設計提高醫藥衛生繫統罕用藥供應的反應性機製,構建政府、企業、患者三維主體協作模式,降低患者的經濟負擔.
목적 탐색제고아국한견병환자용약가급성적관리책략.방법 통과대아국근년전형한견병용약사건진행분석연구、대의원관리화림상의료전가진행방담식문권조사,이급대아국목전한용약의료보험정책진행분석연구,학정약품가급성적함의,명학영향한견병환자용약가급성적장애인소.결과 아국의약위생계통목전주요재과기、공응、신식전체화의료보장능력사개방면존재주、객관장애인소,영향한견병환자용약적가급성,환자정현출용불도약、용약불급시화용불기약적특점.결론 제고아국한견병환자용약적가급성,응명학한견병여한용약적기본개념화격려궤제,설계제고의약위생계통한용약공응적반응성궤제,구건정부、기업、환자삼유주체협작모식,강저환자적경제부담.
Objective To probe into the strategies for improving the accessibility to orphan drugs for patients of rare diseases in China. Methods Analysis of typical cases of orphan drug use in recent years in China, interviews of hospital administrators and clinical doctors, and analysis of the present health insurance policies in China for orphan drugs, definition of the concept of drug accessibility, clarification of the factors hindering orphan drug accessibility. Results Four factors are found to hinder orphan drug accessibility in such aspects of science and technology, supply, information transfer and medical assurance in China's medicine and healthcare system. These subjective and objective factors affect drug accessibility of the patients of rare diseases, denying them of drug accessibility, of drug use in time, and of affordability of such drugs. Conclusion To raise the orphan drug accessibility in China, it is necessary to define basic concepts and incentive mechanism of rare diseases and orphan drug, design and raise the response mechanism of the medicine and health system in orphan drug supply, build a three dimensional cooperation model between such parties as the government, enterprise and patient, and reduce patients' economic burdern.